Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Corre

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
The impact of genomics on the management of myelomaJill Corre, Hervé Avet-Loiseau
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Risk-Based Therapeutic StrategiesJill Corre, Hervé Avet-Loiseau
Stem Cells Translational Medicine|November 6, 2013
Concise review: growth differentiation factor 15 in pathology: a clinical role?Jill Corre, Benjamin Hébraud, Philippe Bourin
Annales De Biologie Clinique|September 22, 2018
IgG lymphoplasmacytic lymphoma: a case reportInès Vergnolle, Nicolas Sigur, Jill Corre
Blood|January 29, 2015
Genetics of multiple myeloma: another heterogeneity level?Jill Corre, Nikhil Munshi, Hervé Avet-Loiseau
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideAurore Perrot, Jill Corre, Hervé Avet-Loiseau
Blood|October 7, 2020
Risk factors in multiple myeloma: is it time for a revision?Jill Corre, Nikhil C Munshi, Hervé Avet-Loiseau
Annales De Biologie Clinique|July 10, 2020
A chance diagnosis of Pelger-Huët anomaly in a 49-year-old woman hospitalized for an acute episode of Crohn diseaseAnaïs Schavgoulidze, Francois Vergez, Jill Corre, et al.
Ejhaem|December 5, 2022
Monoclonal plasma cells with normal phenotype can lead to diagnosis of small B-cell lymphomaAlban Canali, Jill Corre, Brigitte Riviere, et al.
British Journal of Haematology|February 12, 2021
Multiple myeloma with hungry plasma cellsJean-Baptiste Rieu, Aurore Perrot, Ines Vergnolle, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
The impact of genomics on the management of myelomaJill Corre, Hervé Avet-Loiseau
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Risk-Based Therapeutic StrategiesJill Corre, Hervé Avet-Loiseau
Stem Cells Translational Medicine|November 6, 2013
Concise review: growth differentiation factor 15 in pathology: a clinical role?Jill Corre, Benjamin Hébraud, Philippe Bourin
Annales De Biologie Clinique|September 22, 2018
IgG lymphoplasmacytic lymphoma: a case reportInès Vergnolle, Nicolas Sigur, Jill Corre
Blood|January 29, 2015
Genetics of multiple myeloma: another heterogeneity level?Jill Corre, Nikhil Munshi, Hervé Avet-Loiseau
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideAurore Perrot, Jill Corre, Hervé Avet-Loiseau
Blood|October 7, 2020
Risk factors in multiple myeloma: is it time for a revision?Jill Corre, Nikhil C Munshi, Hervé Avet-Loiseau
Annales De Biologie Clinique|July 10, 2020
A chance diagnosis of Pelger-Huët anomaly in a 49-year-old woman hospitalized for an acute episode of Crohn diseaseAnaïs Schavgoulidze, Francois Vergez, Jill Corre, et al.
Ejhaem|December 5, 2022
Monoclonal plasma cells with normal phenotype can lead to diagnosis of small B-cell lymphomaAlban Canali, Jill Corre, Brigitte Riviere, et al.
British Journal of Haematology|February 12, 2021
Multiple myeloma with hungry plasma cellsJean-Baptiste Rieu, Aurore Perrot, Ines Vergnolle, et al.
Pageof 12